Presenting on Emerging Growth Conference 84 Day 2 on July 17; Register to live stream

Presenting on Emerging Growth Conference 84 Day 2 on July 17; Register to live stream GlobeNewswire July 16, 2025 MIAMI, July 16, 2025 (GLOBE NEWSWIRE) — EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 84th Emerging Growth Conference on July 16 & 17, 2025. The Emerging Growth Conference identifies companies […]

As Excitement Builds for HR Tech 2025, HR Executive Reveals Finalists of HR Icons Awards

As Excitement Builds for HR Tech 2025, HR Executive Reveals Finalists of HR Icons Awards Representing World's Leading Organizations, Winners Will Be Announced On-Site This September GlobeNewswire July 16, 2025 WEST PALM BEACH, Fla., July 16, 2025 (GLOBE NEWSWIRE) — With two months to go until HR Tech kicks off in Las Vegas, HR Executive,

OTC Markets Group Welcomes Dowway Holdings Limited to OTCQX

OTC Markets Group Welcomes Dowway Holdings Limited to OTCQX GlobeNewswire July 16, 2025 NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Dowway Holdings Limited (HKEX: 8403; OTCQX: DOWAY), one of the leading integrated exhibition and event

Amphista Therapeutics announces achievement of a research milestone in its collaboration with Merck triggering a milestone payment

Amphista Therapeutics announces achievement of a research milestone in its collaboration with Merck triggering a milestone payment GlobeNewswire July 16, 2025 Collaboration focuses on the discovery of novel, non-CRBN/VHL, Targeted Glue(TM) degraders for oncology and immunology indications Cambridge, UK, 16 July 2025 – Amphista Therapeutics (“the Company” or “Amphista”), a leader in the discovery of

Gauzy Ltd. Sets Date for Second Quarter 2025 Results

Gauzy Ltd. Sets Date for Second Quarter 2025 Results GlobeNewswire July 16, 2025 TEL AVIV, Israel, July 16, 2025 (GLOBE NEWSWIRE) — Gauzy Ltd. (Nasdaq: GAUZ) (“Gauzy” or the “Company”), a global leader in vision and light control technologies, today announced it will release financial results for the second quarter ended June 30, 2025, before

Canadian OCTG Producers File Trade Complaint Against Unfair Imports

Canadian OCTG Producers File Trade Complaint Against Unfair Imports EVRAZ North America and Welded Tube Call on Government of Canada to Defend Domestic Industry GlobeNewswire July 16, 2025 OTTAWA, Ontario, July 16, 2025 (GLOBE NEWSWIRE) — EVRAZ North America and Welded Tube of Canada today announced they have jointly filed an antidumping duty complaint with

Global POISE Study Reaches Milestone of 600 Orthopedic Implants in Pediatric Patients, Advancing Research on the Safety and Efficacy of OrthoPediatrics(R) Products

Global POISE Study Reaches Milestone of 600 Orthopedic Implants in Pediatric Patients, Advancing Research on the Safety and Efficacy of OrthoPediatrics(R) Products GlobeNewswire July 16, 2025 WARSAW, Ind., July 16, 2025 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire July 16, 2025 WATERTOWN, Mass., July 16, 2025 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to

Subtext and SoundCloud Team Up to Bring Artists and Fans Closer Together Through SMS

Subtext and SoundCloud Team Up to Bring Artists and Fans Closer Together Through SMS The new partnership empowers SoundCloud's global community of artists, bands, DJs, and audio creators to build stronger fan connections and generate revenue through texting campaigns that are direct, secure, and fully owned GlobeNewswire July 16, 2025 NEW YORK, July 16, 2025

Voyager Adds Fourth Wholly-Owned Alzheimer’s Disease Program to Pipeline, Complementing Existing Tau and Amyloid Assets with New APOE Approach

Voyager Adds Fourth Wholly-Owned Alzheimer's Disease Program to Pipeline, Complementing Existing Tau and Amyloid Assets with New APOE Approach GlobeNewswire July 16, 2025 – New program combines IV-delivered TRACER(TM) capsid with bifunctional payload to silence APOE in carriers of the high-risk APOE4 variant while delivering the protective APOE2 variant – – Voyager's wholly-owned Alzheimer's disease

Scroll to Top